2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Long-latency somatosensory evoked potentials of the subthalamic nucleus

C. Trenado, S. Elben, L. Friggemann, S. Gruhn, S. Groiss, J. Vesper, A. Schnitzler, L. Wojtecki (Düsseldorf, Germany)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Long-term comparative outcomes of functional neurosurgical procedures for treatment of secondary hemidystonia

W.O. Contreras Lopez, A.R.C. Azevedo, M.G. Guilardi, M. San Martin Sepulveda, R.C.R. Martinez, M.J. Teixeira, E.T. Fonoff (São Paulo, Brazil)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Long-term effects of a short inpatient rehabilitation course and peer support in dystonia

K. Martikainen, S. Kinos, R. Marttila (Turku, Finland)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Long-term effects of levodopa/carbidopa intestinal gel infusion in advanced Parkinson’s disease patients: Dutch multicenter retrospective cohort study

H.R. Moes, J. Groenendal-Laurensse, M. Drent, G. Tissingh, T. van Laar (Groningen, Netherlands)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Long-term effects of pallidal DBS in patients with primary dystonia

P. Krause, S. Völzmann, A. Kupsch, G.H. Schneider, A. Kühn (Berlin, Germany)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Long-term results of pallidal deep brain stimulation in a cohort of eight children with isolated dystonia assessed by blinded video rating

P. Krause, K. Lauritsch, A. Lipp, A. Horn, B. Weschke, A. Kupsch, K. Kiening, G.H. Schneider, A. Kühn (Berlin, Germany)

Pediatric movement disorder  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Long-term safety of levodopa-carbidopa intestinal gel from an ongoing, open-label, phase 3 continued access to treatment study in advanced Parkinson’s disease patients

R.L. Rodriguez, C. Zadikoff, A.J. Espay, V.S.C. Fung, C. Hall, W.Z. Robieson, K. Chatamra, S. Eaton, M.F. Facheris, J. Benesh (Orlando, FL, USA)

Pharmacology

12:00pm-1:30pm

Loss of heart rate variability in ALS: Time and frequency domain assessment

P. Congiu, G. Milioli, G. Borghero, G. Gioi, F. Marrosu, M. Puligheddu, A.L. Goldberger, S. Mariani (Monserratoo, Italy)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3beta activity

C.H. Lin, H.I. Lin, M.L. Chen, T.T. Lai, L.P. Cao, M.J. Farrer, R.M. Wu, C.T. Chien (Taipei, Taiwan)

Pharmacology

12:00pm-1:30pm

LSVT-BIG© case studies: A snapshot of observations

L.A. Dearle (Johannesburg, South Africa)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2